I’m guessing the point of the slide might be that they have different brands so they want to introduce them, but having 4 brands is about far from having a “focus” as you can get… “Our focus” basically translates to we can’t be bothered to explain what’s actually going on in the slide, so read everything and figure it out yourself. I hate when people write one or two words in the header. This is probably better placed at the end of the deck. The company highlights thing is not a terrible idea, but I have no idea what they do yet so it’s rather assumptive. They continue on with the whole “our deck is so special” on the bottom right-hand side so it’s confidential and not for distribution. There is a pointless image on the right that takes up a lot of space and adds no value. Holly hell, really? You need two disclaimer slides? If you absolutely have to, stick in the end, but just don’t even go here. It’s not needed.Įven investment bankers hate having disclaimers in their pitch deck. I have no idea why I would want to invest in this business. This is sort of an introduction to doing happy retreats. ![]() It’s not the worst deck, but it could be easily improved. How you structure slides is very important. There are a bunch of slides that if done properly could be structured together to make a good deck, but as it stands, there is no narrative I can tell. Point is that the founders look at it and think it looks ok so the content must be good. The headers are the most important part of the slide. They refer to what the content on the slide might be about and expect you to read everything. There is a hell of a lot that should be in the deck that is not. Most of the slides are just a list of bullet points with an image slammed on the side. ![]() Pitch deck review summary Novamind Pitch Deck Structured summary review Words Compass is developing psilocybin-based medications to treat mental health illnesses. Compass Pathways, the only psychedelics company to list on the NASDAQ, went public in September and currently has a market value of more than $1.7 billion. Most companies have gone public on Canadian exchanges like the Canadian Securities Exchange (CSE). The company follows in the footsteps of at least a dozen others that have listed publicly in the past few months. Novamind is the latest psychedelics startup looking to list publicly on a Canadian exchange. The company also says it oversees clinical trials of existing compounds and runs psilocybin retreats in Europe and Central America. Novamind currently has clinics in Utah that are set up to administer ketamine-based treatments to patients for mental health conditions. The company is focused on building out an infrastructure that offers a “spectrum of services,” Novamind CEO and cofounder Yaron Conforti told Business Insider. Novamind, a Toronto-based company with operations in the US and Europe, is trying to do a little bit o feverything. Still others are attaining licenses to import and distribute substances while a handful are running “psychedelics retreats” in jurisdictions where such programs are legal. Some are focusing on drug development for regulatory approval, while others are choosing to build out networks of clinics that will be able to deliver those medications to patients. Novamind Ventures is an early-stage investment firm that seeks investments in infrastructure for specialized practitioners to administer psychedelic medicine.Īs the psychedelics industry grows, companies are attempting to position themselves as leaders of different verticals within the space. Also, super lengthy in depth reports.This is the Novamind pitch deck to raise a $10m seed round in 2020. congress debates psilocybin legalization, X province to make announcement on legalization, results of a poll.ĮDITORIAL = Anything that doesn't fit into above OR is clearly an opinion piece speculating the psilocybin market, legalization, effects, benefits, companies. REPORT = Short pieces of news that's not that exciting, not a press release, but still objective, i.e. PRESS RELEASE = Anything from a company or articles that start with "X company is pleased to announce" legalization in a state, country, province / companies merging, buyouts, getting licenses NEWS Flair = Content with big breaking news, i.e. Posts must have a clear connection to the psilocybin mushroom industry Titles must be descriptive, no click-bait titles, use article's actual title in post's wherever possible. Community Rules/Policiesīreaking any of the following rules is grounds for having your post/comment removed ![]() Please subscribe and contribute anything that relates to psilocybin investing. Global drug policy is changing, and psilocybin mushrooms are likely next in line for decriminalization, research, and sale. A community that encourages good investing practices, this sub-reddit intends to educate and prepare investors for the Mush Rush TM.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |